Trustar Capital acquires Chinese throat medicine maker Guilong Pharmaceutical dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
Healthcare holds its own amid a tepid deal market, reaching $444 billion in 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
India is expected to see an upward trajectory in deal activity in 2024, according to a report by Bain & Company s Global Healthcare Private Equity and M&A report. The report cites a surge in healthcare spending and the resilience of pharma manufacturing and services. India overtook China in 2022 in deal volume and value size, and remained top in the Asia Pacific region in 2023. The report predicts 22 healthcare deals in 2023, with deal value reaching $4.6 billion.